Cambourne, United Kingdom

Cambridge Epigenetix Limited

Calculating rank
USPTO Granted Patents = 5


Trademarks = 2

Forward Citations = 59

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Shankar Balasubramanian (3 out of 26 patents)

silverMedal Michael John Booth (2 out of 2 patents)

bronzeMedal Tobias William Barr Ost (1 out of 21 patents)

4.  Oliver Nentwich (1 out of 5 patents)

5.  Toby Ost (1 out of 2 patents)

6.  Neil Matthew Bell (1 out of 1 patent)

7.  Helen Rachel Bignell (1 out of 11 patents)

8.  Tobias Ost (1 out of 2 patents)

9.  David Morley (1 out of 2 patents)

10.  Sidong Liu (1 out of 2 patents)

11.  Joanna Dawn Holbrook (1 out of 2 patents)

12.  Walraj Singh Gosal (1 out of 2 patents)

13.  Jens Fullgrabe (1 out of 2 patents)

14.  Nicolas James Walker (1 out of 2 patents)

15.  Michael Steward (1 out of 2 patents)


5 patents:

Company Overview
Cambridge Epigenetix Limited is a pioneer in the development and application of epigenetic technologies to advance healthcare and drug discovery. The company's innovative solutions enable researchers to uncover valuable insights into the role of epigenetics in health and disease. With a focus on precision medicine and cutting-edge research, Cambridge Epigenetix is committed to driving forward the field of epigenetics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#3 in Cambourne

#3,217 in United Kingdom

Cambourne, GB
Cambourne, United Kingdom
Forward Citations = 59

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cambridge Epigenetix Limited. Retrieved from https://idiyas.com/company/cambridge-epigenetix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…